176 related articles for article (PubMed ID: 20607552)
1. Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer.
Enkelmann A; Heinzelmann J; von Eggeling F; Walter M; Berndt A; Wunderlich H; Junker K
J Cancer Res Clin Oncol; 2011 May; 137(5):751-9. PubMed ID: 20607552
[TBL] [Abstract][Full Text] [Related]
2. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
[TBL] [Abstract][Full Text] [Related]
3. Comparative proteomic analysis of normal and tumor stromal cells by tissue on chip based mass spectrometry (toc-MS).
Escher N; Ernst G; Melle C; Berndt A; Clement JH; Junker K; Friedrich K; Guntinas-Lichius O; von Eggeling F
Diagn Pathol; 2010 Jan; 5():10. PubMed ID: 20205871
[TBL] [Abstract][Full Text] [Related]
4. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
5. Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles.
Modlich O; Prisack HB; Pitschke G; Ramp U; Ackermann R; Bojar H; Vögeli TA; Grimm MO
Clin Cancer Res; 2004 May; 10(10):3410-21. PubMed ID: 15161696
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24.
Cao Y; Yu SL; Wang Y; Guo GY; Ding Q; An RH
Tumour Biol; 2011 Feb; 32(1):179-88. PubMed ID: 20857258
[TBL] [Abstract][Full Text] [Related]
7. Proteomics analysis of bladder cancer exosomes.
Welton JL; Khanna S; Giles PJ; Brennan P; Brewis IA; Staffurth J; Mason MD; Clayton A
Mol Cell Proteomics; 2010 Jun; 9(6):1324-38. PubMed ID: 20224111
[TBL] [Abstract][Full Text] [Related]
8. [Tree analysis pattern of mass spectral urine profiles in differential diagnosis of bladder transitional cell carcinoma].
Wu DL; Zhang YF; Guan M; Liu WW; Xu YM; Jin SB; Zhang J; Jin CR; Lü Y
Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):274-7. PubMed ID: 17760254
[TBL] [Abstract][Full Text] [Related]
9. SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression.
Malik G; Rojahn E; Ward MD; Gretzer MB; Partin AW; Semmes OJ; Veltri RW
Prostate; 2007 Oct; 67(14):1565-75. PubMed ID: 17705230
[TBL] [Abstract][Full Text] [Related]
10. Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis.
Barboro P; Rubagotti A; Orecchia P; Spina B; Truini M; Repaci E; Carmignani G; Romagnoli A; Introini C; Boccardo F; Carnemolla B; Balbi C
Cell Oncol; 2008; 30(1):13-26. PubMed ID: 18219107
[TBL] [Abstract][Full Text] [Related]
11. Protein profiling of bladder cancer using the 2D-PAGE and SELDI-TOF-MS technique.
Langbein S; Lehmann J; Harder A; Steidler A; Michel MS; Alken P; Badawi JK
Technol Cancer Res Treat; 2006 Feb; 5(1):67-72. PubMed ID: 16417404
[TBL] [Abstract][Full Text] [Related]
12. Novel ZEB1 expression in bladder tumorigenesis.
Kenney PA; Wszolek MF; Rieger-Christ KM; Neto BS; Gould JJ; Harty NJ; Mosquera JM; Zeheb R; Loda M; Darling DS; Libertino JA; Summerhayes IC
BJU Int; 2011 Feb; 107(4):656-63. PubMed ID: 20735391
[TBL] [Abstract][Full Text] [Related]
13. [Screening of specific proteins in ultraviolet-induced acute damage of human fibroblasts using proteinchip with surface enhanced laser desorption/ ionization time-of-flight mass spectrometry].
Yan Y; Xu H; Zheng Y; Liu J; Zhang J; Wang B
Zhonghua Yi Xue Za Zhi; 2015 Feb; 95(6):453-6. PubMed ID: 25916784
[TBL] [Abstract][Full Text] [Related]
14. Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy.
Yang G; Tan Z; Lu W; Guo J; Yu H; Yu J; Sun C; Qi X; Li Z; Guan F
J Proteome Res; 2015 Feb; 14(2):639-53. PubMed ID: 25536294
[TBL] [Abstract][Full Text] [Related]
15. A MicroRNA expression profile defining the invasive bladder tumor phenotype.
Wszolek MF; Rieger-Christ KM; Kenney PA; Gould JJ; Silva Neto B; Lavoie AK; Logvinenko T; Libertino JA; Summerhayes IC
Urol Oncol; 2011; 29(6):794-801.e1. PubMed ID: 19945312
[TBL] [Abstract][Full Text] [Related]
16. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
[TBL] [Abstract][Full Text] [Related]
17. Analysis of secreted proteins for the study of bladder cancer cell aggressiveness.
Makridakis M; Roubelakis MG; Bitsika V; Dimuccio V; Samiotaki M; Kossida S; Panayotou G; Coleman J; Candiano G; Anagnou NP; Vlahou A
J Proteome Res; 2010 Jun; 9(6):3243-59. PubMed ID: 20423150
[TBL] [Abstract][Full Text] [Related]
18. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
19. [Biochips in bladder cancer research].
Suhr J; Eisenhardt A; Schmid KW; vom Dorp F; Otto T
Urologe A; 2003 Jul; 42(7):927-32. PubMed ID: 12898036
[TBL] [Abstract][Full Text] [Related]
20. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
